Trends in Immunology
Cytokines sing the blues: inflammation and the pathogenesis of depression
Section snippets
Evidence for increased inflammation in depression
Patients with major depression who are otherwise medically healthy have been repeatedly observed to have activated inflammatory pathways, as manifested by increased proinflammatory cytokines, increased acute-phase proteins and increased expression of chemokines and adhesion molecules 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22. Increased serum and/or plasma concentrations of interleukin (IL)-6 and/or C-reactive protein have been most frequently observed 6, 7, 8, 9, 10, 11, 12
Questions and controversies: does association imply causality?
Although several studies support the idea that inflammatory processes contribute to the pathogenesis of major depression, other studies have failed to find an association between the two 37, 38 and, in some cases, associations have been attenuated or obviated when potential mediating or moderating factors (e.g. body mass index, gender or personality) have been included in the analyses 8, 13, 14, 39. Some positive studies have failed to find a correlation between inflammation and depressive
Pathophysiological mechanisms: immunological pathways to psychopathology
A rich neuropsychiatric literature attests to fundamental mechanisms that conspire to cause the syndrome of major depression. At a neurobiological level, alterations in neurotransmitter function involving serotonin, norepinephrine and dopamine are well known to induce depression and are primary targets for currently available psychopharmacological (antidepressant) treatments [41]. Abnormalities in neuropeptide function are also believed to contribute. Indeed, hypersecretion of the neuropeptide
At the interface between immunology and behavior
Given the primary factors that are associated with the pathophysiology of depression, it is intriguing that peripherally released inflammatory cytokines can access the brain and influence all of the relevant pathophysiological domains (Figure 1). Because of the large size of cytokines and their resultant inability to readily penetrate the blood–brain barrier, attention has been paid to routes by which cytokines access the brain, including (i) entry through leaky regions in the blood–brain
Interferon-α: a clinical model of cytokine-induced depression
To study the effects of innate immune cytokines on behavior in humans, several investigators have seized upon the profound clinical observation that a high percentage of patients who are administered the cytokine interferon (IFN)-α for the treatment of infectious diseases or cancer develop a behavioral syndrome that is strikingly similar to major depression (Figure 2). IFN-α is a potent inducer of proinflammatory cytokines, including IL-6 and, to lesser extent, IL-1 β and TNF-α [54].
Stress and immunity: a crucial link in the cytokine–depression chain
Inflammation is the sine qua non of pathology, so it is understandable that proinflammatory cytokines might contribute to depression in the context of medical illness, thus potentially accounting for the five–tenfold greater prevalence of depression in individuals with a wide range of medical disorders [5]. Nevertheless, it is not as readily apparent what might drive increased inflammation in patients with major depression who are presumably physically healthy. One possibility is the impact of
Evolutionary perspectives
The relationship between depression and activation of innate immune responses might have its roots in the evolutionary advantages of a behavioral repertoire that enables diversion of crucial energy resources to the metabolic demands of fever during times of pathogen exposure. In addition, pathophysiological changes central to depression might protect inflammatory responses from negative regulation by neuroendocrine (glucocorticoid) responses 48, 80 (Box 1). Thus, depression might have been a
Treatment implications
Because paradigm shifts within medicine are judged (finally) by their clinical utility, it is encouraging that important treatment implications have already emerged from our nascent understanding of the role of inflammation in the pathogenesis of major depression. Indeed, data increasingly suggest that inflammatory processes contribute to the therapeutic effects of the currently available antidepressants and could provide targets for novel pharmacological and nonpharmacological treatment
Conclusion
A great amount of compelling data suggest that inflammatory innate immune responses might contribute to the development of depression, in part through complex interactions with stress-responsive pathways involving the neuroendocrine and autonomic nervous systems. The role of the immune system in the pathophysiology of depression probably derives from evolutionary imperatives, and presents intriguing and unique therapeutic opportunities to expand the treatment targets for this disabling and
References (91)
Inflammation-associated cancer: NF-kappaB is the lynchpin
Trends Immunol
(2005)Mood disorders in the medically ill: scientific review and recommendations
Biol. Psychiatry
(2005)Clinical depression and inflammatory risk markers for coronary heart disease
Am. J. Cardiol.
(2002)Potential psychosocial mechanisms linking depression to immune function in elderly subjects
Psychiatry Res.
(2004)Monocytic parameters in patients with dysthymia versus major depression
J. Affect. Disord.
(2004)Cytokine production and treatment response in major depressive disorder
Neuropsychopharmacology
(2000)Abnormal brachial artery flow-mediated vasodilation in young adults with major depression
Am. J. Cardiol.
(2001)Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
Cytokine
(1997)Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis
Eur. Neuropsychopharmacol.
(2001)Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women
Psychoneuroendocrinology
(2004)
Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics
Brain Behav. Immun.
The relation of aggression, hostility, and anger to lipopolysaccharide-stimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men
Brain Behav. Immun.
Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes
Am. J. Cardiol.
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis
J. Psychiatr. Res.
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults
Brain Behav. Immun.
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Biol. Psychiatry
Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders
Curr. Opin. Neurobiol.
Depression: a case of neuronal life and death?
Biol. Psychiatry
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
Eur. J. Pharmacol.
Cytokines and psychopathology: lessons from interferon-alpha
Biol. Psychiatry
p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process
J. Biol. Chem.
The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress
Neuropsychopharmacology
Anterior cingulate activation and error processing during interferon-alpha treatment
Biol. Psychiatry
Peripheral and central proinflammatory cytokine response to a severe acute stressor
Brain Res.
Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation
Behav. Brain Res.
Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist
Neuroscience
Acute stress effects on local Il-1beta responses to pathogens in a human in vivo model
Brain Behav. Immun.
The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety
Cytokine
Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels
Int. J. Cardiol.
The cholinergic anti-inflammatory pathway
Brain Behav. Immun.
Social stress induces glucocorticoid resistance in subordinate animals
Horm. Behav.
Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance
Prog. Neuropsychopharmacol. Biol. Psychiatry
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions
Neuropsychopharmacology
Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock
Brain Res.
Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo
Clin. Therap.
Depression and immunity: a meta-analytic review
Psychol. Bull.
Inflammation, stress, and diabetes
J. Clin. Invest.
Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications
J. Clin. Endocrinol. Metab.
Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings
Am. J. Psychiatry
Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder
Am. J. Psychiatry
Inflammatory proteins and depression in the elderly
Epidemiology
Depression and C-reactive protein in US adults
Arch. Intern. Med.
Association between depression and elevated C-reactive protein
Psychosom. Med.
Major depression and activation of the inflammatory response system
Adv. Exp. Med. Biol.
Cited by (2434)
A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression
2024, PsychoneuroendocrinologyInsights into secondary metabolites and health promoting effects of edible flower Hemerocallis citrina Baroni
2024, Journal of Functional FoodsImmunotherapy for depression: Recent insights and future targets
2024, Pharmacology and TherapeuticsSynergistic effects of citicoline and silymarin nanomicelles in restraint stress-exposed mice
2024, Behavioural Brain ResearchLPS priming-induced immune tolerance mitigates LPS-stimulated microglial activation and social avoidance behaviors in mice
2024, Journal of Pharmacological SciencesThe effect of inflammation markers on cortical thinning in major depressive disorder: A possible mediator of depression and cortical changes
2024, Journal of Affective Disorders